HRP20180793T1 - Farmaceutski pripravak i oblik doziranja koji sadrži dronedaron, te postupak njegove priprave - Google Patents

Farmaceutski pripravak i oblik doziranja koji sadrži dronedaron, te postupak njegove priprave

Info

Publication number
HRP20180793T1
HRP20180793T1 HRP20180793TT HRP20180793T HRP20180793T1 HR P20180793 T1 HRP20180793 T1 HR P20180793T1 HR P20180793T T HRP20180793T T HR P20180793TT HR P20180793 T HRP20180793 T HR P20180793T HR P20180793 T1 HRP20180793 T1 HR P20180793T1
Authority
HR
Croatia
Prior art keywords
dronedarone
preparation
pharmaceutical composition
dosage form
dosage
Prior art date
Application number
HRP20180793TT
Other languages
English (en)
Inventor
Bernard Abramovici
Stéphane Beilles
Jean-Claude Gautier
Sandra Chambonnet
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of HRP20180793T1 publication Critical patent/HRP20180793T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
HRP20180793TT 2010-11-10 2018-05-18 Farmaceutski pripravak i oblik doziranja koji sadrži dronedaron, te postupak njegove priprave HRP20180793T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1059306A FR2967067A1 (fr) 2010-11-10 2010-11-10 Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation
PCT/FR2011/052622 WO2012063005A2 (fr) 2010-11-10 2011-11-10 Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation
EP11796739.8A EP2637645B1 (fr) 2010-11-10 2011-11-10 Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation

Publications (1)

Publication Number Publication Date
HRP20180793T1 true HRP20180793T1 (hr) 2018-06-29

Family

ID=44072520

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20180793TT HRP20180793T1 (hr) 2010-11-10 2018-05-18 Farmaceutski pripravak i oblik doziranja koji sadrži dronedaron, te postupak njegove priprave

Country Status (24)

Country Link
US (2) US9018250B2 (hr)
EP (1) EP2637645B1 (hr)
JP (1) JP2013542244A (hr)
KR (1) KR20140091646A (hr)
CN (1) CN103347502B (hr)
AU (1) AU2011327910A1 (hr)
BR (1) BR112013011763A2 (hr)
CA (1) CA2817310A1 (hr)
CY (1) CY1120418T1 (hr)
DK (1) DK2637645T3 (hr)
ES (1) ES2670445T3 (hr)
FR (1) FR2967067A1 (hr)
HR (1) HRP20180793T1 (hr)
HU (1) HUE037446T2 (hr)
IL (1) IL226183A0 (hr)
LT (1) LT2637645T (hr)
MX (1) MX2013005187A (hr)
PL (1) PL2637645T3 (hr)
PT (1) PT2637645T (hr)
RU (1) RU2013126431A (hr)
SG (1) SG190240A1 (hr)
SI (1) SI2637645T1 (hr)
TR (1) TR201807058T4 (hr)
WO (1) WO2012063005A2 (hr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2967067A1 (fr) * 2010-11-10 2012-05-11 Sanofi Aventis Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation
CN103126994B (zh) * 2011-12-05 2017-03-29 北京虹湾医药技术有限公司 含决奈达隆的固体药物组合物
JP6049409B2 (ja) * 2012-11-08 2016-12-21 中日本カプセル 株式会社 ハードカプセルの製造方法
CN105412027B (zh) * 2015-11-13 2018-10-26 青岛市海慈医疗集团 一种盐酸决奈达隆片剂的制备方法
CN112137999A (zh) * 2020-09-30 2020-12-29 郑州大学 盐酸决奈达隆在制备抗消化道肿瘤药物中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248401A (en) 1966-04-26 Diethylaminoe hoxybenzoyl benzofurans
US4851554A (en) 1987-04-06 1989-07-25 University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4806663A (en) 1987-04-06 1989-02-21 The University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4831054A (en) 1988-04-18 1989-05-16 Taro Pharmaceuticals, Ltd. 2-Alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia
AT391316B (de) 1988-09-15 1990-09-25 Ebewe Arzneimittel Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2665444B1 (fr) 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
US5364880A (en) 1993-06-16 1994-11-15 Advanced Therapies, Inc. Compound for treatment of cardiac arrhythmia, synthesis, and methods of use
FR2764800B1 (fr) * 1997-06-23 1999-09-10 Sanofi Sa Composition pharmaceutique solide contenant des derives de benzofuranne
FR2813306B1 (fr) 2000-08-23 2005-10-21 Sanofi Synthelabo Aminoalkybenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
ITRM20030074A1 (it) * 2003-02-21 2004-08-22 Pharmacia Italia Spa Formulazioni semisolide a rilascio immediato intese
WO2005048979A2 (en) * 2003-10-06 2005-06-02 Torrent Pharmaceuticals Limited Pharmaceutical composition having casing with multiple micro tablets
KR100921947B1 (ko) * 2003-11-19 2009-10-15 (주)아모레퍼시픽 피부 미백 화장료 조성물
KR20090086078A (ko) 2006-10-13 2009-08-10 릴라이언트 파마슈티컬스 인코퍼레이티드 항부정맥제 및 오메가-3 지방산 및 이들의 조합 생성물로의 치료
CN102188417A (zh) 2010-03-19 2011-09-21 江苏恒瑞医药股份有限公司 决奈达隆药物组合物
FR2967067A1 (fr) * 2010-11-10 2012-05-11 Sanofi Aventis Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation

Also Published As

Publication number Publication date
JP2013542244A (ja) 2013-11-21
HUE037446T2 (hu) 2018-09-28
KR20140091646A (ko) 2014-07-22
WO2012063005A2 (fr) 2012-05-18
RU2013126431A (ru) 2014-12-20
SI2637645T1 (en) 2018-06-29
ES2670445T3 (es) 2018-05-30
TR201807058T4 (tr) 2018-06-21
US20150196528A1 (en) 2015-07-16
US9018250B2 (en) 2015-04-28
BR112013011763A2 (pt) 2016-09-13
MX2013005187A (es) 2013-07-03
LT2637645T (lt) 2018-06-11
DK2637645T3 (en) 2018-06-06
FR2967067A1 (fr) 2012-05-11
EP2637645A2 (fr) 2013-09-18
CY1120418T1 (el) 2019-07-10
CN103347502B (zh) 2017-04-26
WO2012063005A3 (fr) 2012-09-13
US20130245115A1 (en) 2013-09-19
PT2637645T (pt) 2018-05-24
CA2817310A1 (fr) 2012-05-18
IL226183A0 (en) 2013-07-31
CN103347502A (zh) 2013-10-09
EP2637645B1 (fr) 2018-02-21
AU2011327910A1 (en) 2013-05-30
SG190240A1 (en) 2013-06-28
PL2637645T3 (pl) 2018-08-31

Similar Documents

Publication Publication Date Title
ZA201209739B (en) Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof
IL225597A0 (en) Pharmaceutical preparation, methods of treatment and its uses
EP2535339A4 (en) POLYMORPHES OF DASATINIB, METHOD OF MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS THEREOF
IL230463A (en) Benzamides, their preparation and their pharmaceutical preparations
IL225824A0 (en) History of quinoxaline, their preparation and pharmaceutical preparations containing them
HRP20180793T1 (hr) Farmaceutski pripravak i oblik doziranja koji sadrži dronedaron, te postupak njegove priprave
PL2562172T3 (pl) Pochodne sfelaktonu, ich kompozycje farmaceutyczne, sposoby wytwarzania i zastosowania
IL232577A (en) History of morpholinylbenzotriazine, their preparation and their pharmaceutical preparations
IL223872A (en) Pyrazoloquinoline derivatives and intermediates, process for preparation, use and pharmaceutical preparations and preparations containing them
EP2924042A4 (en) BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP2786982A4 (en) AMINO-PROPYLENE-GLYCOL DERIVATIVES, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF
IL230219A0 (en) History of dihydropyrazole, their preparation and pharmaceutical preparations containing them
HK1188791A1 (zh) 新型八氫噻吩並喹啉衍生物、包含所述衍生物的藥物組合物及它們的用途
ZA201302012B (en) Low dose pharmaceutical composition
EP2781512A4 (en) OXADIAZOLE COMPOUND AND PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION AND USE THEREOF
HRP20160928T1 (hr) Farmaceutske kompozicije koje sadrže anakinra bez citrata
EP2701689A4 (en) PHARMACEUTICAL COMPOSITIONS OF RALTEEGRAVIR, METHODS OF PREPARATION AND USE THEREOF
HK1162959A1 (en) Pharmaceutical compositions comprising dronedarone
IL225823A0 (en) History of quinazoline, their preparation and pharmaceutical preparations containing them
IL225378A0 (en) History of phenylquinazoline, their preparation and pharmaceutical preparations containing them
EP2926811A4 (en) ARTEMISCULAR PHARMACEUTICAL COMPOSITION, MANUFACTURE AND USE
EP2565180A4 (en) ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE PRODUCTION METHOD AND PHARMACEUTICAL COMPOSITION THEREWITH
IL234614B (en) Pharmaceutical composition and preparation method thereof
HK1136744A2 (en) Butylphthalide self-emulsifying drug delivery system, its preparation method and application
AP2011006026A0 (en) Medicinal and herbal composition.